Skip to content

Aspiration Treatment of Perianal Abscess

Aspiration or Surgical Drainage of Perianal Abscess. A Randomized Controlled Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02585141
Enrollment
111
Registered
2015-10-23
Start date
2015-10-31
Completion date
2020-06-30
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fistulas

Brief summary

The purpose of this study is to compare aspiration and oral antibiotics with surgical incision in the treatment of perianal abscesses in terms of recurrence and subsequent fistula formation. Included patients will be randomised to either aspiration or incision.

Detailed description

Anorectal abscess is a common condition, caused by cryptoglandular polymicrobial infection, where the traditional treatment is surgical drainage. Anorectal abscess is associated with recurrence rates between 6-44 % after surgical drainage and persistent subsequent fistula up to 37 %. Inadequate incision, missed abscess components or fistulas can be the cause of recurrence . Surgical drainage is associated with discomfort from prolonged wound healing, affecting the daily activities as well as the potential risk of complicated scaring and fecal incontinence. Less invasive method with pus aspiration under antibiotic cover has been shown to be safe in terms of recurrence rate and subsequent fistula formation and well tolerated by the patients with less morbidity and wound complications and a potential lower risk of fecal incontinence. However, this has been shown only in few studies with small population and no randomized controlled study comparing the two approaches has been conducted or published to our knowledge. The risk factors of recurrence and subsequent fistula formation are not that clear but age below 40 years, absence of diabetes mellitus and recent smoking are shown to be risk factors for developing recurrent abscess and fistula. Applying aspiration and antibiotics method for the treatment of perianal abscess can be an advantage for the society due to a shorter recovering period, quicker return to daily activity and work and avoiding wound healing problems and sphincter damage; thus lower expenses. The results of this study have the potentials to reveal the risk factors of developing fistula after perianal abscess.

Interventions

DEVICEMEDIPLAST® (aspiration)

The aspiration drainage will be with a large caliber needle (MEDIPLAST® 13 G, 2,5 x 110 mm) and a syringe of 20 ml. The cavity must be emptied for pus and irrigated by repeated injection and aspiration of saline until clear fluid is obtained.

PROCEDUREincision

Incision drainage will be undertaken as standardized de-roofing of the abscess and debridement. Wound packing and dressing will not be used, just sitz bath or ordinary hygiene until wound healing.

DRUGClindamycin

Postoperative broad spectrum oral antibiotics covering both aerobes and anaerobes bacteria will be given for seven days of Clindamycin 300 mg tablets x 3 a day

Sponsors

Odense University Hospital
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥18 yrs old 2. Perianal abscess (without spontaneous rupture) 3. Abscess larger than 2 cm in diameter 4. Signed informed consent

Exclusion criteria

1. Malignancy within 5 yrs 2. Previous radiotherapy of the abdomen and pelvis 3. Recurrent abscess within 6 months 4. Immune suppressed patients 5. Pregnant and lactating women 6. Abscess with horseshoe formation 7. Allergy to Clindamycin

Design outcomes

Primary

MeasureTime frameDescription
Change in recurrence rate2,12 and 52 weeksRate of recurrences of abscesses in each arm after 2,12 and 52 weeks

Secondary

MeasureTime frameDescription
changes in Quality of life score2,12 and 52 weeksChanges in Short Form Health Survey (SF-36) questionaire after 2,12 and 52 weeks
fecal incontinence2,12 and 52 weekschanges in Wexner fecal incontinence score after 2,12 and 52 weeks
Risk factors for fistula formation and abscess recurrence2,12 and 52 weeksrisk factors for recurrences and fistula formation as; age, gender, BMI, smoking and alcohol use. Furthermore presence or absence of the following medical conditions: diabetes mellitus, ischemic cardiac disease, arrhythmia, hypertension, asthma/ COLD, connective tissue disease and renal function impairment. As well as the characteristics of perianal abscess: number of abscesses, localization, distance from anus in cm, largest diameter in cm, length of symptoms and use of antibiotics prior to admission. Finally bacterial culture.Risk factors of developing fistula after both treatments; both medical and abscess related will be analyzed using multivariate analysis.
Changes in healing time2,12 and 52 weekstime to recovery and wound healing after both procedures and it will be measured as the number of days between operation and healed wound.
Changes in fistulas formation2,12 and 52 weeksrate of fistula formation in each arm after 2,12 and 52 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026